1-15 of 15
Merlin C. Thomas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes

Merlin C. Thomas, Mark Woodward, Bruce Neal, Qiang Li, Raelene Pickering, Michel Marre, Bryan Williams, Vlado Perkovic, Mark E. Cooper, Sophia Zoungas, John Chalmers, Graham S. Hillis
Journal: Diabetes Care
Diabetes Care 2015;38(10):1891–1897
https://doi.org/10.2337/dc15-0925
Published: 07 August 2015
View article titled, Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes
Open the PDF for Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Osteopontin Is a Strong Predictor of Incipient Diabetic Nephropathy, Cardiovascular Disease, and All-Cause Mortality in Patients With Type 1 Diabetes

Daniel Gordin, Carol Forsblom, Nicolae M. Panduru, Merlin C. Thomas, Mette Bjerre, Aino Soro-Paavonen, Nina Tolonen, Niina Sandholm, Allan Flyvbjerg, Valma Harjutsalo, Per-Henrik Groop
Journal: Diabetes Care
Diabetes Care 2014;37(9):2593–2600
https://doi.org/10.2337/dc14-0065
Published: 07 August 2014
View article titled, Osteopontin Is a Strong Predictor of Incipient Diabetic Nephropathy, Cardiovascular Disease, and All-Cause Mortality in Patients With Type 1 Diabetes
Open the PDF for Osteopontin Is a Strong Predictor of Incipient Diabetic Nephropathy, Cardiovascular Disease, and All-Cause Mortality in Patients With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Added Value of Soluble Tumor Necrosis Factor-α Receptor 1 as a Biomarker of ESRD Risk in Patients With Type 1 Diabetes

Carol Forsblom, John Moran, Valma Harjutsalo, Tony Loughman, Johan Wadén, Nina Tolonen, Lena Thorn, Markku Saraheimo, Daniel Gordin, Per-Henrik Groop, Merlin C. Thomas
Journal: Diabetes Care
Diabetes Care 2014;37(8):2334–2342
https://doi.org/10.2337/dc14-0225
Published: 12 July 2014
View article titled, Added Value of Soluble Tumor Necrosis Factor-α Receptor 1 as a Biomarker of ESRD Risk in Patients With Type 1 Diabetes
Open the PDF for Added Value of Soluble Tumor Necrosis Factor-α Receptor 1 as a Biomarker of ESRD Risk in Patients With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Relationship Between Urinary Sodium Excretion Over Time and Mortality in Type 2 Diabetes

Elif I. Ekinci, John L. Moran, Merlin C. Thomas, Karey Cheong, Sophie Clarke, Angela Chen, Matt Dobson, Amanda Leong, Richard J. MacIsaac, George Jerums
Journal: Diabetes Care
Diabetes Care 2014;37(4):e62–e63
https://doi.org/10.2337/dc13-1947
Published: 08 March 2014
View article titled, Relationship Between Urinary Sodium Excretion Over Time and Mortality in Type 2 Diabetes
Open the PDF for Relationship Between Urinary Sodium Excretion Over Time and Mortality in Type 2 Diabetes in another window
Journal Articles

Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes

Daniel Gordin, MD, Aino Soro-Paavonen, MD, Merlin C. Thomas, MBCHB, Valma Harjutsalo, PHD, Markku Saraheimo, MD, Mette Bjerre, PHD, Carol Forsblom, DMSC, Allan Flyvbjerg, MD, Per-Henrik Groop, MD, on behalf of the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2013;36(7):1827–1833
https://doi.org/10.2337/dc12-2170
Published: 12 June 2013
View article titled, Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes
Open the PDF for Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes in another window
Journal Articles

Response to Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709

Elif I. Ekinci, MBBS, Richard J. MacIsaac, PHD, Merlin C. Thomas, PHD, George Jerums, MD
Journal: Diabetes Care
Diabetes Care 2011;34(7):e125–125
https://doi.org/10.2337/dc11-0834
Published: 17 June 2011
View article titled, Response to Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709
Open the PDF for Response to Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709 in another window
Journal Articles

The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes

Merlin C. Thomas, MBCHB, John Moran, MD, Carol Forsblom, DMSC, Valma Harjutsalo, MD, Lena Thorn, MD, Aila Ahola, MD, Johan Wadén, MD, Nina Tolonen, MD, Markku Saraheimo, MS, Daniel Gordin, MSC, Per-Henrik Groop, MD, for the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2011;34(4):861–866
https://doi.org/10.2337/dc10-1722
Published: 21 March 2011
View article titled, The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes
Open the PDF for The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes

Elif I. Ekinci, MBBS, Sophie Clarke, MBBS, Merlin C. Thomas, PHD, John L. Moran, MD, Karey Cheong, BSCI, Richard J. MacIsaac, PHD, George Jerums, MD
Journal: Diabetes Care
Diabetes Care 2011;34(3):703–709
https://doi.org/10.2337/dc10-1723
Published: 17 February 2011
View article titled, Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes
Open the PDF for Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)

Merlin C. Thomas, MBCHB, PHD, Richard J. MacIsaac, MBBS, PHD, George Jerums, MBBS, MD, Andrew Weekes, MD, John Moran, MD, PHD, Jonathan E. Shaw, MD, PHD, Robert C. Atkins, MD, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(8):1497–1502
https://doi.org/10.2337/dc08-2186
Published: 26 May 2009
View article titled, Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)
Open the PDF for Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11) in another window
Journal Articles

HDL Composition Predicts New-Onset Cardiovascular Disease in Patients With Type 1 Diabetes

Per-Henrik Groop, MD, DMSC, Merlin C. Thomas, MBCHB, PHD, Milla Rosengård-Bärlund, MD, Vashti Mills, BSC, Mats Rönnback, MD, Stephen Thomas, PHD, MRCP, Carol Forsblom, MD, DMSC, Maria-Rita Taskinen, MD, DMSC, Giancarlo Viberti, FRCP
Journal: Diabetes Care
Diabetes Care 2007;30(10):2706–2707
https://doi.org/10.2337/dc07-0030
Published: 01 October 2007
View article titled, HDL Composition Predicts New-Onset Cardiovascular Disease in Patients With Type 1 Diabetes
Open the PDF for HDL Composition Predicts New-Onset Cardiovascular Disease in Patients With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Identification of Obesity in Patients With Type 2 Diabetes From Australian Primary Care: The NEFRON-5 Study

Merlin C. Thomas, MBCHB, PHD, FRACP, Paul Zimmet, MD, PHD, FRACP, FACE, FAFPHM, AO, Jonathan E. Shaw, MD, MRCP, FRACP
Journal: Diabetes Care
Diabetes Care 2006;29(12):2723–2725
https://doi.org/10.2337/dc06-1288
Published: 01 December 2006
View article titled, Identification of Obesity in Patients With Type 2 Diabetes From Australian Primary Care: <subtitle>The NEFRON-5 Study</subtitle>
Open the PDF for Identification of Obesity in Patients With Type 2 Diabetes From Australian Primary Care: <subtitle>The NEFRON-5 Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Is Nonalbuminuric Renal Insufficiency in Type 2 Diabetes Related to an Increase in Intrarenal Vascular Disease?

Richard J. MacIsaac, BSC(HONS), PHD, MBBS, FRACP, Sianna Panagiotopoulos, BSC(HONS), PHD, Karen J. McNeil, MBBS, FRACP, MPH+TM, Trudy J. Smith, BSC, MAPPSC, Con Tsalamandris, MBBS, Huming Hao, MD, DMU, P. Geoffrey Matthews, MBBS, PHD, DDU, FRACP, Merlin C. Thomas, MBCHB, FRACP, PHD, David A. Power, FRACP, PHD, George Jerums, MBBS, FRACP, MD
Journal: Diabetes Care
Diabetes Care 2006;29(7):1560–1566
https://doi.org/10.2337/dc05-1788
Published: 01 July 2006
View article titled, Is Nonalbuminuric Renal Insufficiency in Type 2 Diabetes Related to an Increase in Intrarenal Vascular Disease?
Open the PDF for Is Nonalbuminuric Renal Insufficiency in Type 2 Diabetes Related to an Increase in Intrarenal Vascular Disease? in another window
Journal Articles

Serum Lipids and the Progression of Nephropathy in Type 1 Diabetes

Merlin C. Thomas, MBCHB, PHD, FRACP, Milla Rosengård-Bärlund, MD, Vashti Mills, BSC, Mats Rönnback, MD, Stephen Thomas, PHD, MRCP, Carol Forsblom, MD, DMSC, Mark E. Cooper, MBBS, PHD, Marja-Riitta Taskinen, MD, DMSC, Giancarlo Viberti, MD, FRCP, Per-Henrik Groop, MD, DMSC
Journal: Diabetes Care
Diabetes Care 2006;29(2):317–322
https://doi.org/10.2337/diacare.29.02.06.dc05-0809
Published: 01 February 2006
View article titled, Serum Lipids and the Progression of Nephropathy in Type 1 Diabetes
Open the PDF for Serum Lipids and the Progression of Nephropathy in Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Metabolic Syndrome in Type 1 Diabetes: Association with diabetic nephropathy and glycemic control (the FinnDiane study)

Lena M. Thorn, MD, Carol Forsblom, MD, DMSC, Johan Fagerudd, MD, DMSC, Merlin C. Thomas, MD, PHD, Kim Pettersson-Fernholm, MD, DMSC, Markku Saraheimo, MD, Johan Wadén, MD, Mats Rönnback, MD, Milla Rosengård-Bärlund, MD, Clas-Göran af Björkesten, MD, Marja-Riitta Taskinen, MD, DMSC, Per-Henrik Groop, MD, DMSC, on behalf of the FinnDiane Study Group
Journal: Diabetes Care
Diabetes Care 2005;28(8):2019–2024
https://doi.org/10.2337/diacare.28.8.2019
Published: 01 August 2005
View article titled, Metabolic Syndrome in Type 1 Diabetes: <subtitle>Association with diabetic nephropathy and glycemic control (the FinnDiane study)</subtitle>
Open the PDF for Metabolic Syndrome in Type 1 Diabetes: <subtitle>Association with diabetic nephropathy and glycemic control (the FinnDiane study)</subtitle> in another window
Journal Articles

Unrecognized Anemia in Patients With Diabetes: A cross-sectional survey

Merlin C. Thomas, MBCHB, Richard J. MacIsaac, PHD, Con Tsalamandris, MBBS, David Power, MD, PHD, George Jerums, MD
Journal: Diabetes Care
Diabetes Care 2003;26(4):1164–1169
https://doi.org/10.2337/diacare.26.4.1164
Published: 01 April 2003
View article titled, Unrecognized Anemia in Patients With Diabetes: <subtitle>A cross-sectional survey </subtitle>
Open the PDF for Unrecognized Anemia in Patients With Diabetes: <subtitle>A cross-sectional survey </subtitle> in another window